SNDL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient buyer. Despite oversold conditions and bullish-leaning options positioning, the primary trend remains bearish (SMA_200 > SMA_20 > SMA_5), there are no Intellectia entry signals, and the pattern-based outlook skews negative over the next month (-5.31%). A better risk-reward entry would typically come after a clear trend reversal or a confirmed bounce off support with improving momentum.
Trend: Bearish. The moving average stack is negative (SMA_200 > SMA_20 > SMA_5), indicating downside control across long/medium/short timeframes. Momentum: RSI_6 at 28.24 suggests the stock is oversold/near-oversold and could see a reflex bounce, but oversold alone is not a buy trigger in a downtrend. MACD: Histogram is slightly above zero (0.000283) but positively contracting, implying bullish momentum is weak and fading rather than accelerating. Levels: Pivot 1.571. Near-term support at S1 1.487 (then S2 1.435). Resistance at R1 1.655 and R2 1.707. With price ~1.545, it’s sitting between pivot and S1—more “breakdown risk” than “breakout confirmation.” Quant/Pattern read: Similar-pattern stats imply ~0.18% next day, -0.53% next week, and -5.31% next month, reinforcing the bearish swing bias.
Options positioning is bullish-leaning (low put/call ratios), and IV is relatively low (cheap optionality), which can support short-term upside attempts.
RSI near oversold may enable a short-term technical bounce, especially if 1.487 support holds.
Revenue grew +3.09% YoY in 2025/Q3, indicating some top-line stability.
Primary price trend is still bearish (MA structure negative), and MACD momentum is weakening.
No recent news catalysts reported; lack of event-driven upside drivers.
Pattern-based forward stats skew negative over 1 week to 1 month (notably -5.31% over next month).
Profitability deteriorated in 2025/Q3: net income more negative and EPS worse YoY.
Latest quarter: 2025/Q3. Revenue increased to $244.219M (+3.09% YoY), but profitability weakened: Net Income fell to -$13.319M (down -31.09% YoY) and EPS declined to -0.05 (down -28.57% YoY). Gross margin was 20.98% (slightly up +0.24% YoY). Overall: modest growth but worsening earnings, which typically caps sustained upside unless a clear turnaround catalyst emerges.
No analyst rating or price target change data was provided, so a Wall Street pros/cons trend read can’t be confirmed from the dataset. Based on available fundamentals alone, the ‘pro’ case is modest revenue growth and stable gross margin; the ‘con’ case is continued losses and deteriorating YoY earnings metrics. Politician/congress activity: No recent congress trading data available, and no influential-figure transactions were provided.
